Tuesday, June 6, 2023

Veterinary Medicines—a study on 50 Major Medicines with Projected Sales

The prevalence of animal diseases, disorders and illnesses has put the spotlight on veterinary medicines. Farmers and pet owners bank on drugs to keep their animal disease free and healthy. The medicine can also be used to control and monitor zoonotic diseases and maintain livestock food supply. Veterinarians also work in agribusiness to ensure a safe food supply, while also helping farmers boost their productivity. 

The rising allergic disease among dogs has prompted industry leaders to inject funds into research and development programs and product rollouts. In January 2022, Zoetis announced European Commission marketing authorization for Apoquel chewable tablets for dogs. It will help treat pruritus and provide enough time for veterinarians to identify the cause of allergic disease in dogs. The database lists dogs as the most represented targeted species (65%).  

The huge repository of Grand View Research includes competitive insights exhibiting forward-looking companies’ strategic approaches to bolster their market penetration in veterinary medicine. For instance, in 2021, the top four animal health products in Boehringer Ingelheim led to net sales of more than EUR 1,894 million. The final report, along with the database, will deep-dive into the following dynamics:

Insights on molecules/active ingredients, including Lokivetmab, maleate, Amoxicillin, Selamectin, Pyrantel and Ivermectin.

Inputs on regulatory approvals, patent information, ASP and competition from generics, among others. 

Analysis of a diverse portfolio of diagnose products and veterinary medicines. For instance, pharmaceuticals (most represented in the database) account for 72% share of the total products.

Assessment of anti-inflammatory, antiparasitic, antibiotics and dermatology products. 

Get your copy or request a free sample of the report “50 Key Veterinary Medicines with Estimated Sales, 2018 – 2022,” collated and published by Grand View Research. 

Key Veterinary Medicine Report Scope

Scope

Details

Brand name

Marketed name of the Product e.g., Simparica/Simparica Trio

INN

Name of the Active Ingredient or Generic Name. The database includes Oclacitinib maleate, Lokivetmab, Selamectin, Amoxicillin, Ivermectin, Pyrantel, and others.

Molecular Weight

Weight of each active ingredient molecule in grams per mole (g/mol)

Company

Name of the Company manufacturing/ marketing the Product. The database includes leading animal health companies such as Zoetis, Virbac, Elanco, and Boehringer Ingelheim International GmbH

First Approval/ Launch Year

The year that indicates the first ever launch of the product. For example, Apoquel was first launched in 2014 by Zoetis. Note: Most of the products in the database have been launched between 2000 and 2015

Indication

Specifies approved uses of the product. For instance, the database includes products indicated for dermatitis, pain, osteoarthritis, parasitic diseases, bacterial infections, etc.

Type

Specifies the type of the product such as Pharmaceuticals/ Vaccines/ Medicated Feed Additives

Category

Specifies the category or sub-type of the product such as antiparasitic, antibiotic, anti-inflammatory, and dermatology. Anti-infective products such as antiparasitics, and antibiotics are the most dominant in the database.

Dosage Form

The database includes dosage forms such as injectables, tablets, sprays, and collars, among others.

Target Species

Dogs dominate the database in terms of target species while others include cats and cattle.

Estimated Sales

Specifies global revenue of the product in USD million from 2018 to 2022. The highest revenue generated by a product in 2021 was estimated at about USD 750 million.

ASP (in USD)

Average Selling Price per unit in line with the dosage form

Commercialized/ Available in

Regions/ countries where the product is sold

Patent/ Generics Information

Qualitative information about patents, patent expiry, and generics is provided as per the availability of information. For instance, the patents covering the commercial formulation of a product in the database expire in the U.S. in October 2023 and in Brazil in 2025.

Other Notes

Any other relevant information about the product or any recent initiative covering the product launch, upgrade, etc. For instance, Apoquel by Zoetis is the first Janus kinase inhibitor approved for use in veterinary medicine.

Deliverable Format

MS Excel/ Dashboard



About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.


Monday, June 5, 2023

A Comprehensive Guide to ESG in 3D Printing Industry

Sustainability priorities of environmental stewardship, workers’ safety, human rights and sound governance have become pronounced in the 3D printing industry. Additive manufacturing (AM) technology and solutions are well-placed to influence global issues and foster improvements through innovations, training, education and carbon footprint reduction. 3D printing, post-COVID-19, has become a game-changer as companies seek to assess the untapped potential of additive manufacturing. Prominently, 3D printing has amassed huge popularity among manufacturers, engineers and designers to keep up with the need for responsible energy consumption. Moreover, recycling, reducing, repurposing, reusing and repairing have ushered innovation in the global landscape. Companies are expected to exhibit product improvements and complement transparency, fairness, regulated, ethical and compliant operations.

3D printed parts and products have become palpable in end-products, including athletic shoes and printed cars. Stakeholders are exhibiting traction for additive manufacturing programs and embracing the responsibility to enhance lives and protect the environment. Exponential growth in digitization and a paradigm shift witnessed in the energy transition towards renewables have redefined the 3D printing landscape. Additive manufacturing could be instrumental in aerospace, manufacturing, automotive and healthcare sectors to reduce lead time, and material cost, leverage on-site production and underpin growth with sustainability targets. Amidst surging pressure to address supply chain issues and keep up with energy efficiency needs, industry players could explore opportunities in 3D printing. 

Key Companies in this theme

    • Stratasys, Ltd

    • Materialise

    • EnvisionTec Inc

    • 3D Systems Inc

    • GE Additive

    • Autodesk Inc

    • Canon Inc.

Discover more regarding the practices and strategies being implemented by industry participants from the 3D Printing Industry ESG Thematic Report, 2023, published by Astra ESG Solutions

Environmental Perspective 

A notable shift towards AM technologies could lead to less energy consumption, reduced waste, optimized and enhanced supply chains and more recycling. In July 2021, eight companies joined the bandwagon to be part of the Additive Manufacturer Green Trade Association (AMGTA) to educate and promote the green upsides of 3D printing. Similarly, in May 2022, the global trade organization announced that 20 member companies received the 2022 Sustainability Awards. AM technologies are expected to boost environmentally friendly methods of manufacturing, mainly attributed to the innate ability to manufacture closer to the point of need, minimize material consumption and redesign parts to reduce energy consumption and weight. 

Pioneering products, services and state-of-the-art technologies are unlocking opportunities and measuring sustainability metrics in line with ESG goals. The trend has become prevalent and prompted stakeholders to inject funds into sustainability portfolios. In December 2020, 3D Systems announced the rollout of its ESG initiative, bolstering its commitment to leveraging AM solutions for a host of applications. Companies are poised to advocate for sustainable technologies that will help minimize carbon emissions and eradicate waste. Notably, AM uses merely the material required to produce the final part, thereby playing an invaluable role in bolstering sustainability. 

Social Perspective

3D printing has come on the horizon as a vital cog in fostering employees’ health and safety and social programs, including entrepreneurship and STEAM education. In April 2022, it was reported that Stratasys offered access to dozens of 3D printers and funded the FIRST Robotics Competition for high school students. The company also introduced the “learning by making” program with Jerusalem Municipality, spanning across state-religious, independent-religious, state-secular and Arab schools. Additionally, the company was reported to be resilient amidst havoc wracked by the COVID-19 pandemic. Stratasys inferred in its 2020-2021 ESG and Sustainability Report that it reduced the work to 80% capacity till the end of 2020. It helped them do away with the pandemic-induced layoffs. The company offered mental health seminars on depression, social connections and loneliness. Besides, it organized an in-person summer camp in 2021 to provide fun and relief to the teams and their families.

Stakeholders have furthered their focus on diversity to add value for shareholders, employees and customers. In doing so, embracing diverse teams could propel an inclusive culture and complement employees’ unique identities, experiences and backgrounds. For instance, in 2021, GE updated a few voluntary self-identification categories and selections pertaining to sexual orientation and gender identity (based on employee feedback). The company asserted in its 2021 Diversity Annual Report that around 3.7% of its U.S. employees identified themselves as having a disability, while over 10% of the U.S. employees are military veterans. Amidst call for equal pay for all, GE is gearing to attain 100% pay equity in each of its businesses.

Is your business one of participants of the Global 3D Printing Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices.

Governance Perspective

Stakeholders demand greater traceability and transparency as companies seek to build trust with customers, communities, investors and other parties. Corporate governance has come to the fore as an invaluable pillar to running a business sustainably. Additive manufacturing companies are expected to devote attention to corporate governance policies, and guidelines and invest in data-driven products and solutions. Leading players are emphasizing independent leadership for a robust compliance and internal controls with applicable laws, policies and regulations. Notably, Autodesk infers in its 2022 Impact Report that 90% of its Board of Directors are independent, while 50% are women. 

Stakeholders are counting on AI and ML to streamline the business. Forward-looking companies anticipate additive manufacturing to foster logistics systems and bolster resilience through the incorporation of environmental and social aspects. Leading players are likely to prioritize sustainability reporting frameworks to further organizations’ governance disclosure. In essence, GE offers disclosure as per SASB standards and provides climate-related disclosures in line with the TCFD framework. For instance, the organization has been disclosing how it assesses, identifies and manages climate-related risks. Meanwhile, Eaton has set an audacious target (2030 Sustainability Target) of over 50% enhancements in safety metrics, disclose U.S. minority and global gender pay equity assurance results, and ensure no human rights violation from major suppliers. It has also set report priority issues in line with TCFD and SASB requirements. The company asserted that around 65% of its net sales stemmed from sustainable solutions in 2021. 

As 3D printing brings a seismic shift in the global landscape, stakeholders are gearing to augment their leadership position in ESG. In doing so, prominent manufacturers and suppliers are poised to inject funds into organic and inorganic growth strategies. To illustrate, in November 2022, Stratasys announced the pouring of USD 10 million in Axial3D, wherein both companies will render a joint offering to provide the accessibility of patient-specific 3D printing solutions for medical device manufacturers and hospitals. Prevailing trends indicate the global 3D printing market size could register an impressive CAGR of 20.8% from 2022 through 2030. Industry dynamics suggest sustainability priorities will witness an upward growth trajectory with a focus on, including but not limited to, people-first strategies, innovation, climate actions and transparency. 

About Astra – ESG Solutions By Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research

Sunday, June 4, 2023

Why ESG is Key to the Future of Cloud Computing Industry

Environmental, social and governance (ESG) performance has become invaluable in minimizing carbon footprint, boosting waste management and enhancing board diversity in the cloud computing industry. The rising footprint of cloud services across healthcare, automotive, media, gaming, financial services, public services and e-commerce has furthered the need to bolster the sustainability profile. Brands are expected to use AR/VR, edge computing, big data, blockchain and cloud-native technologies to foster brand recognition, complement sound corporate behavior and bolster sustainable investing. 

ESG strategies have gained prominence in the wake of surging environmental awareness and consumers’ willingness to pay premium prices for sustainable products. Environmentally and socially conscious practices have become prevalent to attract and retain investors and customers. Cloud computing service providers have exhibited profound traction to expedite their ESG progress. For instance, the Google Cloud Platform offers carbon-free energy scores for Google Cloud regions, enabling companies to choose GCP locations optimized for reduced carbon emissions

Key Companies in this theme

    • Adobe Inc.

    • Alibaba Group Holding Limited

    • Amazon.com Inc.

    • Google LLC

    • International Business Machines Corporation

    • Microsoft Corporation 

    • Toshiba Corporation

Discover more regarding the practices and strategies being implemented by industry participants in the Cloud Computing Industry ESG Thematic Report, 2023, published by Astra ESG Solutions

Environmental Perspective

The global push to meet sustainability goals has prompted forward-looking organizations to achieve their ESG objectives. Industry leaders are inclined to use green equipment in data centers to minimize power consumption. Moreover, businesses are expected to receive impetus from recycling and reuse to reduce waste and capital expenditure. In essence, Google suggests that 5 of its data centers operate at almost 90% carbon-free energy (CFE). With data centers continuing to be sought-after in the energy transition, sustainable cloud services will witness investments galore. In August 2021, the American giant announced an infusion of USD 1.2 billion in Germany’s Cloud Computing Program by 2030 to undergird cloud computing infrastructure and renewable energy usage. 

Social Perspective

Diversity representation and the emphasis on inclusivity have become a viable portfolio to foster a positive change within the company and across societies. Prominently, women account for over 30% of the Microsoft workforce globally. Moreover, women in technical roles have risen between 1.4 and 1.6% points over the past half a decade. It has also embarked on a mission to represent the population of people with disabilities. As of June 2022, around 7.8% of the Microsoft employees in the core business in the U.S. self-identified as having a disability. With the global push to propel racial equity, the company has injected around USD 150 million to reinforce inclusion and the number of U.S. Black and African American and Hispanic and Latinx people managers, senior leaders and senior individual contributors by 2025. An emphasis on diversity, equity and inclusion will redefine computing solutions and help employees be more innovative and creative. 

Is your business one of participants to the Global Cloud Computing Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices.

Governance Perspective

Cloud-based management can unlock avenues of growth in ESG with increased transparency, data standardization, and process automation. Tax transparency, board diversity, executive pay, and sound governance structure will leverage companies to create long-term value. Brands and institutions have fostered governance frameworks and brought new skills and global perspectives. To put this in perspective, eleven out of 12 director nominees are independent in IBM. Meanwhile, two women directors and three ethnically diverse directors were included in the past three years, according to the IBM 2021 ESG report. The American giant has an Audit committee to help identify financial and audit risks with the assistance of IBM’s enterprise management framework about AI ethics, privacy and cyber. Development of practices and policies that emphasize transparency, trust, ethics and accountability could be pronounced, auguring well for the industry growth. 

The competitive landscape indicates an increased focus on organic and inorganic strategies, such as technological advancements, product offerings, mergers & acquisitions, innovations and collaborations. For instance, in October 2022, Alibaba announced opening a new campus with investments in cloud computing. The design of the campus is reportedly eco-friendly, including flowerpots made from recycled plastic, a photovoltaic power generation system and high-efficiency low-energy devices in the on-site coffee shop. The global cloud computing market size was pegged at USD 368.97 billion in 2021 and could observe a 15.7% CAGR between 2022 and 2030. 

About Astra – ESG Solutions By Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research


Friday, June 2, 2023

The Importance of ESG in the Specialty Chemicals Industry

Environmental, social and governance (ESG) portfolio strategies have become paramount for specialty chemicals manufacturers. An increased emphasis on sustainability could open avenues of organic growth to serve as a foundation for strong financial performance. With specialty chemicals witnessing bullish demand across industry verticals, the challenges and opportunities have become more pronounced pertaining to sustainability, health & safety and governance policies. These trends have made ESG a top priority for boards, venture capitalists, investors and other stakeholders.

Chemical companies are well-positioned to inject funds into sustainability initiatives, including hydrogen production and advanced recycling. Companies have also shown traction for near-zero emissions, net-zero emissions and carbon neutrality by 2050. With chemical companies being held accountable for sourcing raw materials sustainably, investments in bullish ESG practices will gain ground. Moreover, the prevalence of stringent environmental regulation has furthered the prominence of sustainability. For instance, specialty chemicals produced from waste materials, including furfural from biomass and polyols from waste gas could gain ground to recycle waste into products.

Financial and non-financial performances pertaining to ESG have become pronounced. Prominently, specialty chemical companies are gearing up to boost health & safety and environmental stewardship. Corporate players are overcoming challenges on the back of diversity and sound corporate governance. ESG strategies adopted by leading companies are elucidated below:

Environmental Perspective

Global push to minimize emissions, waste management, water management and underpin biodiversity has ramped up investments in the environmental strategy. Specialty chemicals companies grapple with waste, toxicity and pollution, compelling them to face litigation or liabilities. Chemical producers have exhibited increased traction to be in line with the objectives of the Task Force on Climate-related Financial Disclosures (TCFD).

Climate reporting has become pronounced with the growing adoption of TCFD. Furthermore, well-established players have set a bullish target to combat climate change. For instance, Evonik aims to reduce absolute scope 1 and 2 emissions by 50% by 2025 (compared to the 2008 level). It also vies to minimize scope 3 emissions from the upstream value chain by 15% by 2025 (compared with 2020 base). The Germany-headquartered company has also earmarked sites that would be most affected by water stress in the next two decades. It contemplates 5% reduction of absolute energy consumption and energy consumption relative to production by 2025.

Is your business one of participants to the Specialty Chemicals Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

Social Perspective

Companies that are working towards the development and well-being of people and emphasize an inclusive working environment are expected to stay ahead of their competitors. A robust ESG practice also demands hiring and engagement practices that complement employee diversity. Nova Chemicals is gearing up to rev up the representation of women across all levels of the organization to 30% by 2030. The Canada-based company is vying for a 10% surge in diversity across all levels and a 5% rise in representation of people of color in leadership by 2030 (from 2020 baseline).

Notably, the development of a strong talent pipeline and emphasis on training can underscore the social pillar. Chemical companies have also shown a bullish approach to safety through the establishment of a safety culture, promotion of safety awareness, interaction and implementation of hazard recognition training and learning policies. For instance, Nova asserts its employees recorded over 57,000 safety interactions while working from home or at the workplace. Safety programs and vision to achieve zero injuries are expected to reinforce the core values of ESG.

Governance Perspective

A company's corporate behavior, board diversity, anti-competitive practices, transparency and business ethics are the precursor to sound and effective governance. Strong corporate governance practices have become instrumental to underscore the value of the company and ensure efficient use of resources. In essence, the Supervisory Board at BASF has at least 50% members from various professional experiences and educational backgrounds. Furthermore, the company is on course to propel the representation of women in leadership positions to 30% by 2030 with disciplinary responsibility.  It has also furthered its approach to anti-money laundering to foster transparent business relationships. Besides, concerted efforts to protect sensitive information, including Know-how and prevent misuse or unauthorized disclosure have also gained ground across the business vertical.

The integration of sustainability into strategic management and the inclusion of social and environmental aspects in the portfolio will reshape the global landscape. These dynamics are expected to encourage key players to ramp up their ESG efforts. To illustrate, in August 2021, Evonik issued €500 million (USD 543 million) to bolster its sustainability portfolio. It reportedly published Green Finance Framework and is striving to minimize its ecological footprint. Prevailing trends suggest the specialty chemicals market size garnered USD 586.5 billion in 2020 and could witness around 4.3% CAGR from 2021 through 2028. Grand View Research expects promising growth opportunities for companies with an emphasis on sustainability.

About Astra – ESG Solutions by Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research


Sunday, May 28, 2023

Continuous Glucose Monitoring (CGM) Devices—a deep-dive on How Athletics Trend Redefines Digital Health

Athletes have exhibited immense traction in tracking glucose levels continuously. So much so that CGM technology has become sought-after to see how their training and food influence their blood glucose levels all the time. The advanced CGM devices enable consumers to make diet and training decisions to help boost their performance. There have been instances in the past of the National Football League (NFL) using CGM devices. Some well-established brands, such as Abbott (Libre Sense), Supersapiens and Nutrisense, have furthered their penetration to tap into the global market. 

Sports and fitness enthusiasts have joined the bandwagon to enhance their fitness performance. It is worth mentioning that CGM is less invasive and some devices can be connected to Bluetooth, making the product highly popular among amateur and professional athletes. Grand View Research is gearing up to add OTC CGM devices used in non-diabetes applications and their impact on the blood glucose monitoring device market in its repository. The final report, coupled with the database, will emphasize the following dynamics:

Opportunities for CGM manufacturers and analytics service providers

Trends that can influence the prospect and application of CGM devices in fitness enthusiasts and diabetic patients.

Insights on Medicare and Medicaid coverage.

CGMs pricing among athletes and patients.

Get your copy or request a free sample of the report “A Study On New Vertical Growth Opportunities for Continuous Glucose Monitoring Devices,” compiled and published by Grand View Research. 

Vertical Growth Opportunities for CGM Devices Report Scope

Attribute

Details

Patient Demographics

  • Total Population
  • People with diabetes
  • People with undiagnosed diabetes
  • Deaths attributable to diabetes
  • Sport enthusiasts
  • Number of athletes

Pricing

Pricing for CGMs in diabetic patients vs Athletes

Reimbursement Differences

Coverage for Medicare and Medicaid

Regions

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait


About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Thursday, May 25, 2023

Diabetes Type 1 and Type 2—a Study on Country-wise Disease Demographics

The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks. 

Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:

Decision-making process and customer buying pattern.

Reimbursement landscape and diabetes-related expenditure per person.

Treatment options and related costs across countries.

Comparative prevalence of diabetes.

Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research. 

Disease Demographics for Diabetes Type 1 and Type 2 Report Scope

Attribute

Details

Patient Demographics

  • Total Population
  • People with diabetes
  • People with undiagnosed diabetes
  • Deaths attributable to diabetes

Treatment Options

  • Type 1 Diabetes
    • Insulin
    • Diet
    • Blood glucose monitoring
  • Type 2 Diabetes
    • Oral Medications
    • Diet
    • Exercise
    • Blood glucose monitoring
    • Insulin

Treatment Cost Per Patient

  • Total diabetes-related health expenditure, USD Million
  • Diabetes-related health expenditure per person, USD

Quality of Life

  • Disability-adjusted life years (DALYs)

Comorbidity Analysis

  • Diabetic foot ulcer
  • Cardiovascular disease (CVD)
  • Diabetic retinopathy
  • Diabetic neuropathy
  • Diabetic nephropathy

Reimbursement Differences

  • Coverage for Medicare and Medicaid
    • Type 1 Diabetes
    • Type 2 Diabetes

Regions

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Related Reports:

About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Wednesday, May 24, 2023

Viral Vector—Perusal on Adeno-associated Viruses (AAVs) in Gene Therapy Development

The medical industry expects viral vectors to grow in prominence in transferring genetic material into the genetic composition of cells. Adeno-associated Viruses (AAVs) have become sought-after in gene therapy as they can deliver genetic material to cells and do not cause disease. Predominantly, adenovirus, retrovirus, herpes simplex virus and lentivirus, among others, are used to transfer genetic material into cells’ genetic composition. Technological advancements in manufacturing AAV vectors have encouraged stakeholders to boost their portfolios. An uptick in research activities in viral vector-based cell and gene therapies has redefined the global landscape. For instance, in 2020, over 100 gene-therapy products were observed in clinical trials.

Pharma companies, investors, venture capitalists and other stakeholders will possibly explore the growth potential in viral vectors. The final report, along with the database, will deep-dive into the following industry dynamics:

AAV vectors approved by governing bodies, including FDA and the European Medicines Agency. Zolgensma was approved by EMA and FDA in 2020 and 2019, respectively, while Luxturna received the green signal from FDA in 2017 and EMA in 2018. 

Insights on potential challenges for AAV manufacturers, such as cost, degradation during supply chain and preparation of stable viral vectors.

Influence of the COVID-19 pandemic on vaccine development.

Acquisitions of biotech startups

Get your copy or request a free sample of the report “Viral Vector Development - Focus on Adeno-associated Virus, 2018 – 2021,” compiled and published by Grand View Research.

Viral Vector Report Scope

Attribute

Details

Market Lineage

  • % Captured by AAV within Viral Vectors
  • Understanding of the parent market and ancillary industries
    • Plasmid DNA Contract Manufacturing
    • Cell & Gene Therapy Clinical Trials Market

Industry Dynamics

  • Viral Vector based gene therapy development
  • AAV Development workflow
  • Pipeline for AAV
  • Capitalist funding in the industry
  • Development Process

Deep dive Analysis

  • Understanding of AAV v/s Lentiviral v/s other viral vectors
  • Cost of manufacturing (based on batch size) - a case study
  • Case study on setting up a development plant

Competition Analysis in CDMOs

  • Companies with products in clinical trials
  • Various bioreactors used for development
  • Strategic initiatives undertaken in the last 5 years

Observation and Recommendations

This section will summarize the entire study and provide analyst insights with regards to key methods of development, technological advancements, and competitive profiling


About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

ESG Initiatives In The Bakery Product Industry

Embedding the value of environmental, social and governance (ESG) in the  bakery product industry  has become a vital cog in augmenting reve...